Ben Bronstein's most recent trade in Aldeyra Therapeutics Inc was a trade of 62,728 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 62,728 | 62,728 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 3,860 | 3,860 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 3,619 | 3,619 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,282 | 40,282 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,778 | 2,778 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,604 | 2,604 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 21,222 | 21,222 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 1,464 | 1,464 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 1,372 | 1,372 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 9,604 | 0 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.55 per share. | 27 Jun 2023 | 9,604 | 28,248 (0%) | 0% | 0.6 | 5,301 | Common Stock |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 53,812 | 53,812 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 3,711 | 3,711 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 3,479 | 3,479 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 13,534 | 13,534 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 933 | 933 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 875 | 875 | - | - | Stock Option (Right to Buy) |